Regen BioPharma, Inc. (RGBP)
OTCMKTS · Delayed Price · Currency is USD
0.000155
-0.000045 (-22.50%)
At close: Jun 15, 2026
Regen BioPharma Market Cap
Regen BioPharma has a market cap or net worth of $112.39 thousand as of June 15, 2026. Its market cap has decreased by -87.59% in one year.
Market Cap
112.39K
Enterprise Value
1.09M
Revenue
236.56K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 4, 2014, Regen BioPharma's market cap has decreased from 19.72M to 112.39K, a decrease of -99.43%. That is a compound annual growth rate of -35.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 112.39K | -85.94% |
| Dec 31, 2025 | 799.61K | -47.23% |
| Dec 31, 2024 | 1.52M | -57.47% |
| Dec 29, 2023 | 3.56M | -81.90% |
| Dec 30, 2022 | 19.69M | -70.55% |
| Dec 31, 2021 | 66.86M | 9,040.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endonovo Therapeutics | 180.76K |
| GB Sciences | 158.82K |
| Immunotech Laboratories | 114.99K |
| Synairgen | 110.27K |
| Innovation Pharmaceuticals | 105.75K |
| Sigyn Therapeutics | 99.18K |
| PaxMedica | 88.39K |
| Affymax | 81.94K |